Insider trades
Jonathan Goldman, Director of Avalo Therapeutics AVTX, has filed 0 purchases and 2 sales on the open market. Over the past 12 months that comes to a net sale of $163K. The latest trade was on 03/28.
Jonathan Goldman
Director
- Company
- Avalo Therapeutics AVTX
- First filing
- 24/08/14
- Trades
- 11 trades
- Buys / sales
- 0 / 2
- 12-month net buying
- −$163K
- Last trade
- 03/28
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
AVTX | Open-market sale | 25/11/14 | 25/11/17 | 11,367 sh2 trades | $14.34avg. | $162,958.1 | −100.0% |